21Shares Ethereum ETF (TETH)
Live price chart, market sentiment, and community perspectives for 21Shares Ethereum ETF (CBOE: TETH).
Live price chart, market sentiment, and community perspectives for 21Shares Ethereum ETF (CBOE: TETH).
On our macro desk, the narrative around TETH is entirely dictated by the brutal H1 2026 numbers. Watching net assets collapse by 58.73% down to roughly $12.91 million while shares outstanding dropped from 2,110,000 to 1,640,000 tells us that redemptions are severely outpacing creations. Even though the 0.21% expense ratio is competitive, the broader risk-off environment and fee compression moving to L2 scaling solutions have neutered protocol-level revenue. Sentiment on the Street is heavily cautious; this is not an environment where scale-driven competitors or smaller single-asset spot funds can easily thrive without a macro trend reversal.
Reviewing the structural risk profile of TETH, the 10-Q filing for the period ended June 30, 2026, underscores extreme underlying volatility. With a 1-year historical volatility sitting around 53.80% and maximum drawdowns crossing 65%, the product is explicitly exposed to rapid crypto price swings. Furthermore, the fund is not registered under the Investment Company Act of 1940, meaning it lacks the regulatory protections of traditional mutual funds. Investors face total loss risks, custodian security dependencies, and structural vulnerability to reflexive ETF outflows if macro shocks persist.
From a quantitative modeling standpoint, our systems have flagged TETH with a 'Strong Sell' rating, giving it a 2/10 AI score as of August 2026. The quantitative probability of beating the broader ETF universe over a 3-month horizon sits under pressure, with negative technical contributors like the 180-day chart pattern and unfavorable 'Long ETH, Short USD' risk dynamics outweighing positive flow momentum. When evaluating entry points for clients asking about direct spot exposure, I advise cross-referencing these automated probability scores against the persistent threat of protocol-level revenue bleeding into alternative execution layers.
Explore plasma cleansing, somatic organ swaps, and BCI.